EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities by Yedier-Bayram, O, Gokbayrak, B, Kayabolen, A, Aksu, AC, Cavga, AD, Cingöz, A, Kala, EY, Karabiyik, G, Günsay, R, Esin, B, Morova, T, Uyulur, F, Syed, H, Philpott, M, Cribbs, AP, Kung, SHY, Lack, NA, Onder, TT, Bagci-Onder, T